Search

everythinglearnresearchcommunity

for

Search:↓

Imiquimod shows promise as a non-invasive treatment for certain HPV-related lesions, but more research is needed to optimize its use.

5-alpha reductase inhibitors don't increase breast cancer or benign breast disorder risk in women.

Herbal medicine may help treat breast cancer and improve quality of life.

A drug called cimetidine can help treat hair loss in women by blocking androgen receptors. However, it's not the first choice and needs more research.

Targeted anticancer therapies often cause skin issues, affecting treatment adherence and quality of life.

A new compound slows cancer cell growth and causes cell death by blocking cell cycle progression and increasing cell-damaging molecules.

Doxazosin may cause breast enlargement and pain in men.

Etanercept is safe and may help improve hidradenitis suppurativa, but more research is needed.

A woman with severe angioedema improved significantly after treatment with rituximab.

Laser therapy on human skin affects the HERC6 gene and related genes, influencing many cell processes and requiring careful safety measures.

Eflornithine cream effectively reduces facial hair in women with hirsutism.

Certain genes can predict how well breast cancer patients respond to chemotherapy.

Oral 5-alpha reductase inhibitors do not increase breast cancer or benign breast disorder risk in women.

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

Metformin is effective for treating excessive hair growth in women with PCOS and may work better than the standard treatment in some ways.

Surgical removal of a rare ovarian tumor improved symptoms and hormone levels in a postmenopausal woman.

Long-term use of 5α-reductase inhibitors may improve survival in men with kidney cancer.

Erythematous papulopustular eruptions in cancer patients using EGFR inhibitors show specific skin changes that vary with severity and treatment type.

Tamoxifen can cause total hair loss but its benefits outweigh this side effect.

The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.

Gefitinib can cause rare scarring hair loss.

Certain drugs that block specific enzymes can help treat prostate diseases.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Hormone Replacement Therapy improves skin health in postmenopausal women by boosting collagen and hydration.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Gefitinib can cause hair and eyebrow darkening.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.